Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic MelanomaToso, J. F. · Journal of Clinical Oncology · 2002

Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I EvaluationThamm, D. H. · Clinical Cancer Research · 2005

Contribution of MHC class I-dependent immune mechanisms induced by attenuated recombinant Salmonella typhimurium secreting superoxide dismutase to protection against murine listeriosisLeander Grode; Stefan H.E. Kaufmann; Jürgen Hess · 2001

Phase I Study of the Intravenous Administration of Attenuated <i>Salmonella typhimurium</i> to Patients With Metastatic MelanomaToso, John F.; Gill, Vee J.; Hwu, Patrick; Marincola, Francesco M.; Restifo, Nicholas P.; Schwartzentruber, Douglas J.; Sherry, Richard M.; Topalian, Suzanne L.; Yang, James C.; Stock, Frida; Freezer, Linda J.; Morton, Kathleen E.; Seipp, Claudia; Haworth, Leah; Mavroukakis, Sharon; White, Donald; MacDonald, Susan; Mao, John; Sznol, Mario; Rosenberg, Steven A. · Journal of Clinical Oncology · 2002

<i>Editorial:</i> What Ails Solid Tumor Radioimmunotherapy?Divgi, Chaitanya · Cancer Biotherapy & Radiopharmaceuticals · 2006

Tools for Pretargeted RadioimmunotherapyWu, Anna M. · Cancer Biotherapy & Radiopharmaceuticals · 2001

AmifostineRasey, Janet S. · Cancer Biotherapy & Radiopharmaceuticals · 1999

Cancer ImmunotherapyDillman, Robert O. · Cancer Biotherapy & Radiopharmaceuticals · 2011

Radiobiology of Systemic Radiation TherapyMurray, David; McEwan, Alexander J. · Cancer Biotherapy & Radiopharmaceuticals · 2007

The Immune System and CancerLoose, David; Van de Wiele, Christophe · Cancer Biotherapy & Radiopharmaceuticals · 2009

Fundamentally DifferentOldham, Robert K. · Cancer Biotherapy & Radiopharmaceuticals · 1999

Oral PresentationsCancer Biotherapy & Radiopharmaceuticals · 2004